Lupin informs about press release

28 Sep 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 28th September 2020 as regards launch by the Company of Fosaprepitant for Injection, 150 mg Single-Dose Vial, having received an approval from the US FDA earlier.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2122.60 -28.45 (-1.32%)
01-Feb-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.85
Lupin 2122.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×